Peripheral arterial disease progression and ankle brachial index: a cohort study with newly diagnosed patients with type 2 diabetes

Table 2 Laboratorial data from non-drug naive and drug-naive T2DM patients at the beginning of the study

	Group 1 (non-drug naive)	Group 2 (drug-naive)	p
	N = 978	N = 221	p
Glycemia (mg/dL)	174 ± 56	187 ± 65	< 0.05
Glycated hemoglobin (%)	8.6 ± 1.6	8.9 ± 2.1	< 0.001
Glomerular filtration ratio (mL/min)	84 ± 24	106 ± 34	< 0.001
Albuminuria (mg/g)	168 ± 170	38 ± 101	< 0.001
Total cholesterol (mg/dL)	198 ± 48	212 ± 55	< 0.001
Triglycerides (mg/dL)	207 ± 115	222 ± 154	0.8
HDL-C(mg/dL)	43 ± 11	41 ± 9	< 0.05
LDL-C (mg/dL)	115 ± 41	130 ± 42	< 0.001

T2DM Type 2 diabetes mellitus, NS Not significant, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol. Group 1 Individuals with T2DM undergoing drug treatment, Group 2 Newly diagnosed drug-naive (< 3 months) patients with T2DM. Statistical significance was set at p < 0.05

ISSN: 1471-2261